Lacosamide in patients with epilepsy of cerebrovascular etiology.
Felix RosenowChristian BrandtAli BozorgSvetlana DimovaBjörn Steiniger-BrachYing ZhangBruno FerròGregory L HolmesReetta KälviäinenPublished in: Acta neurologica Scandinavica (2020)
These exploratory post hoc analyses suggested lacosamide was generally well tolerated and effective in patients with CVEE, with data from the initial monotherapy trial suggesting numerically better efficacy than carbamazepine-CR.